
Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories





Discovery Science
October 8, 2025


Sign up to receive email notifications
Explore more topics
Sign up

Mayo Clinic Connect
An online patient support community